10x Genomics (NASDAQ:TXG) Sets New 1-Year Low After Analyst Downgrade
10x Genomics, Inc. (NASDAQ:TXG – Get Free Report)’s share price reached a new 52-week low on Monday after Barclays lowered their price target on the stock from $19.00 to $18.00. Barclays currently has an overweight rating on the stock. 10x Genomics traded as low as $12.37 and last traded at $12.59, with a volume of […]
10x Genomics, Inc. (NASDAQ:TXG – Get Free Report)’s share price reached a new 52-week low on Monday after Barclays lowered their price target on the stock from $19.00 to $18.00. Barclays currently has an overweight rating on the stock. 10x Genomics traded as low as $12.37 and last traded at $12.59, with a volume of […]
